| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
10,410 |
509 |
$1.60M |
| 90999 |
Unlisted dialysis procedure, inpatient or outpatient |
7,101 |
549 |
$998K |
| J1270 |
Injection, doxercalciferol, 1 mcg |
4,328 |
371 |
$780K |
| J1756 |
Injection, iron sucrose, 1 mg |
1,795 |
384 |
$312K |
| A4657 |
Syringe, with or without needle, each |
652 |
519 |
$148K |
| 83540 |
|
567 |
488 |
$76K |
| 83550 |
|
567 |
488 |
$76K |
| 83970 |
|
435 |
376 |
$63K |
| 85041 |
|
315 |
271 |
$56K |
| 85048 |
|
315 |
271 |
$56K |
| J0604 |
Cinacalcet, oral, 1 mg, (for esrd on dialysis) |
338 |
161 |
$42K |
| 85046 |
|
164 |
154 |
$27K |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
130 |
71 |
$26K |
| 82728 |
|
181 |
164 |
$25K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
84 |
79 |
$10K |
| G0008 |
Administration of influenza virus vaccine |
32 |
31 |
$8K |
| 90674 |
|
23 |
22 |
$6K |